Novo Nordisk shot helps teens lose weight, new study finds
Wegovy has already been approved for adult use, and the Danish drugmaker has now demonstrated that its obesity drug can provide a weight-loss effect for adolescents as well.
By Immanual John Milton, bloomberg
Novo Nordisk A/S’s weekly shot that reduces obesity in adults returned promising results in teens, according to a study that adds to a growing wave of potential interventions for the stubborn condition.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk on track to secure Wegovy doses
For subscribers
